Zubin Master

3.5k total citations
93 papers, 2.2k citations indexed

About

Zubin Master is a scholar working on Physiology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Zubin Master has authored 93 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Physiology, 42 papers in Public Health, Environmental and Occupational Health and 24 papers in Molecular Biology. Recurrent topics in Zubin Master's work include Biomedical Ethics and Regulation (46 papers), Ethics in Clinical Research (36 papers) and Pluripotent Stem Cells Research (13 papers). Zubin Master is often cited by papers focused on Biomedical Ethics and Regulation (46 papers), Ethics in Clinical Research (36 papers) and Pluripotent Stem Cells Research (13 papers). Zubin Master collaborates with scholars based in United States, Canada and Australia. Zubin Master's co-authors include Daniel Dumont, David B. Resnik, Robert S. Kerbel, Jennifer M. Tran, Timothy Caulfield, Elise Smith, Janusz Rak, Joanne Yu, Nina Jones and J. V. Jones and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Biological Chemistry.

In The Last Decade

Zubin Master

86 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zubin Master United States 25 978 558 539 308 220 93 2.2k
Sharon F. Terry United States 34 1.2k 1.2× 935 1.7× 457 0.8× 331 1.1× 158 0.7× 175 4.5k
Alan E. Guttmacher United States 28 2.0k 2.1× 569 1.0× 218 0.4× 372 1.2× 338 1.5× 56 8.0k
Julie Park United States 26 1.6k 1.6× 247 0.4× 276 0.5× 319 1.0× 336 1.5× 121 4.2k
Kelly E. Ormond United States 34 1.1k 1.2× 1.7k 3.0× 488 0.9× 198 0.6× 776 3.5× 121 6.4k
Bruce R. Korf United States 52 2.7k 2.8× 846 1.5× 638 1.2× 670 2.2× 987 4.5× 242 11.1k
Clara Gaff Australia 35 550 0.6× 723 1.3× 124 0.2× 428 1.4× 324 1.5× 152 3.9k
Anneke Lucassen United Kingdom 41 962 1.0× 1.3k 2.4× 447 0.8× 858 2.8× 434 2.0× 187 6.1k
Brenda F. Kurland United States 43 581 0.6× 295 0.5× 185 0.3× 1.1k 3.5× 706 3.2× 122 5.5k
Anita Lal United States 33 2.7k 2.7× 478 0.9× 565 1.0× 809 2.6× 877 4.0× 88 5.0k
Ségolène Aymé France 38 1.2k 1.3× 683 1.2× 459 0.9× 68 0.2× 163 0.7× 161 4.7k

Countries citing papers authored by Zubin Master

Since Specialization
Citations

This map shows the geographic impact of Zubin Master's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zubin Master with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zubin Master more than expected).

Fields of papers citing papers by Zubin Master

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zubin Master. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zubin Master. The network helps show where Zubin Master may publish in the future.

Co-authorship network of co-authors of Zubin Master

This figure shows the co-authorship network connecting the top 25 collaborators of Zubin Master. A scholar is included among the top collaborators of Zubin Master based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zubin Master. Zubin Master is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Master, Zubin, et al.. (2025). Physicians' Views on Orthobiologics. Cytotherapy. 27(5). S129–S129. 1 indexed citations
3.
Watson, Sara, Alessandro R Marcon, Xuan Zhu, et al.. (2024). Descriptions of Scientific Evidence and Uncertainty of Unproven COVID-19 Therapies in US News: Content Analysis Study. PubMed. 4. e51328–e51328.
4.
Zhu, Xuan, David T. Eton, Lila J. Finney Rutten, et al.. (2023). Designing persuasive health education for patients seeking unproven stem cell interventions. Stem Cell Reports. 18(8). 1549–1554. 3 indexed citations
5.
Sisk, Bryan A., et al.. (2022). Prescribing unproven cancer drugs: physician perspectives on expanded access and right to try. Journal of Law and the Biosciences. 9(2). lsac031–lsac031.
6.
Smith, Cambray, Megan Munsie, Atta Behfar, et al.. (2021). Academic Physician Specialists’ Approaches to Counseling Patients Interested in Unproven Stem Cell and Regenerative Therapies—A Qualitative Analysis. Mayo Clinic Proceedings. 96(12). 3086–3096. 5 indexed citations
7.
Smith, Cambray, Jan C. Buckner, Alex A. Adjei, et al.. (2021). Oncologists’ reflections on patient rights and access to compassionate use drugs: A qualitative interview study from an academic cancer center. PLoS ONE. 16(12). e0261478–e0261478. 4 indexed citations
8.
Smith, Cambray, Alex A. Adjei, Jan C. Buckner, et al.. (2020). “I Think It’s Been Met With a Shrug:” Oncologists’ Views Toward and Experiences With Right-to-Try. JNCI Journal of the National Cancer Institute. 113(6). 735–741. 7 indexed citations
9.
Smith, Cambray, et al.. (2020). Challenging Misinformation and Engaging Patients: Characterizing a Regenerative Medicine Consult Service. Regenerative Medicine. 15(3). 1427–1440. 19 indexed citations
10.
Master, Zubin, et al.. (2020). Dosimetric comparison of RapidPlan and manually optimised volumetric modulated arc therapy plans in prostate cancer. Journal of Radiotherapy in Practice. 20(3). 257–264. 1 indexed citations
11.
Master, Zubin, et al.. (2020). Stem cell preservation for regenerative therapies: ethical and governance considerations for the health care sector. npj Regenerative Medicine. 5(1). 23–23. 10 indexed citations
12.
Master, Zubin, et al.. (2018). Conflicts of interest policies for authors, peer reviewers, and editors of bioethics journals. AJOB Empirical Bioethics. 9(3). 194–205. 6 indexed citations
13.
Smith, Elise & Zubin Master. (2017). Best Practice to Order Authors in Multi/Interdisciplinary Health Sciences Research Publications. Accountability in Research. 24(4). 243–267. 44 indexed citations
14.
Murdoch, Blake, Vardit Ravitsky, Ubaka Ogbogu, et al.. (2017). Non-invasive Prenatal Testing and the Unveiling of an Impaired Translation Process. Obstetrical & Gynecological Survey. 72(5). 270–272. 1 indexed citations
15.
Master, Zubin, et al.. (2016). Multisite Research Ethics Review: Problems and Potential Solutions. SHILAP Revista de lepidopterología. 2 indexed citations
16.
Master, Zubin, Amy Zarzeczny, Christen Rachul, & Timothy Caulfield. (2013). What's Missing? Discussing Stem Cell Translational Research in Educational Information on Stem Cell “Tourism”. The Journal of Law Medicine & Ethics. 41(1). 254–268. 20 indexed citations
17.
Master, Zubin. (2012). The Governance of Research Integrity in Canada. 20(3). 5. 3 indexed citations
18.
Voskas, Daniel, Nina Jones, Paul Van Slyke, et al.. (2005). A Cyclosporine-Sensitive Psoriasis-Like Disease Produced in Tie2 Transgenic Mice. American Journal Of Pathology. 166(3). 843–855. 67 indexed citations
19.
Slyke, Paul Van, Mariano Loza‐Coll, Zubin Master, et al.. (2005). Dok-R Mediates Attenuation of Epidermal Growth Factor-Dependent Mitogen-Activated Protein Kinase and Akt Activation through Processive Recruitment of c-Src and Csk. Molecular and Cellular Biology. 25(9). 3831–3841. 29 indexed citations
20.
Jones, Nina, Zubin Master, J. V. Jones, et al.. (1999). Identification of Tek/Tie2 Binding Partners. Journal of Biological Chemistry. 274(43). 30896–30905. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sharon F. Terry Breakdown of academic impact, for papers by Alan E. Guttmacher Breakdown of academic impact, for papers by Julie Park Breakdown of academic impact, for papers by Kelly E. Ormond Breakdown of academic impact, for papers by Bruce R. Korf Breakdown of academic impact, for papers by Clara Gaff Breakdown of academic impact, for papers by Anneke Lucassen Breakdown of academic impact, for papers by Brenda F. Kurland Breakdown of academic impact, for papers by Anita Lal Breakdown of academic impact, for papers by Ségolène Aymé
Rankless by CCL
2026